HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment with rivaroxaban of cerebral venous thrombosis and bone marrow necrosis induced by pegaspargase: A case report and literature review.

AbstractRATIONALE:
Pegaspargase has been used in the treatment of acute lymphoblastic leukemia with promising results. However, it has also been associated with several potentially serious complications, including thrombosis. Pegaspargase-induced cerebral venous thrombosis and bone marrow necrosis are very rare.
PATIENT CONCERNS:
A 50-year-old female developed headache, weakness of the right lower extremity, fever, and bone pain after chemotherapy including pegaspargase for the treatment of acute lymphoblastic leukemia.
DIAGNOSES:
Her imaging studies and bone marrow examinations were compatible with cerebral venous thrombosis and bone marrow necrosis.
INTERVENTIONS:
The patient received anticoagulation therapy with rivaroxaban.
OUTCOMES:
After treatment with rivaroxaban, she had a good outcome without major or minor bleeding.
LESSONS:
Clinicians should be aware of the very rare but possible induction of bone marrow necrosis during pegaspargase treatment when there is necrosis in other organs. Because of its greater safety and convenience, rivaroxaban gains popularity over traditional anticoagulant drugs.
AuthorsJingrui Sui, Yongming Zhang, Liqing Yang, Hui Wang, Junqing Xu, Rongxia Wei, Yaping Hao, Xiaolei Wang, Jun Peng, Junjie Ma
JournalMedicine (Medicine (Baltimore)) Vol. 96 Issue 46 Pg. e8715 (Nov 2017) ISSN: 1536-5964 [Electronic] United States
PMID29145310 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Antineoplastic Agents
  • Polyethylene Glycols
  • pegaspargase
  • Rivaroxaban
  • Asparaginase
Topics
  • Antineoplastic Agents (adverse effects)
  • Asparaginase (adverse effects)
  • Bone Marrow (pathology)
  • Female
  • Humans
  • Middle Aged
  • Necrosis (chemically induced, drug therapy)
  • Polyethylene Glycols (adverse effects)
  • Remission Induction
  • Rivaroxaban (therapeutic use)
  • Sinus Thrombosis, Intracranial (chemically induced, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: